An Overview of FDA Medical Device Regulation as it Relates to Deep Brain Stimulation Devices
Carlos Peña, Kristen A. Bowsher, Ann H. Costello, Robert De Luca, Sara Doll, Khan Li, M. Schroeder, Theodore Stevens
Abstract
Carlos Peña, Kristen A. Bowsher, Ann H. Costello, Robert De Luca, Sara Doll, Khan Li, M. Schroeder, Theodore Stevens
Abstract
The United States Food and Drug Administration (FDA) is charged with assuring the safety and effectiveness of a variety of medical products and the FDA's Center for Devices and Radiological Health is responsible for premarket and postmarket regulation of medical devices. In this paper, we review--from device classification and clinical studies to the final marketing application--FDA's premarket requirements and postmarket requirements as they relate to deep brain stimulation devices.
OpenAlex reports 39 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The United States Food and Drug Administration (FDA) is charged with assuring the safety and effectiveness of a variety of medical products and the FDA's Center for Devices and Radiological Health is responsible for premarket and postmarket regulation of medical devices. In this paper, we review--from device classification and clinical studies to the final marketing application--FDA's premarket requirements and postmarket requirements as they relate to deep brain stimulation devices.
Key concepts: Food and drug administration, Medical device, Medicine, Deep brain stimulation, Risk analysis (engineering), Business, Biomedical engineering, Pathology